Health
TransThera Announced Global Phase 3 Clinical Trial for Cholangiocarcinoma Authorized in the European Union and Orphan Drug Designation for Tinengotinib to Treat Biliary Tract Cancer Granted by European Medicines Agency
NANJING, China and GAITHURSBURG, Md., March 8, 2024 /PRNewswire/ -- TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced that the randomized, controlled, global multicenter Phase 3 trial (FIRST-308) of tinengotinib versus ph...
"AXA Women's Health Centre" officially unveils on International Women's Day
AXA and Chiron Medical join hands to introduce Hong Kong's first women-exclusive health centre Comprehensive care for women's health with an entire female medical team at the helm HONG KONG, March 8, 2024 /PRNewswire/ -- Commemorating International Women's Day on 8 March, AXA Hong Kong andMacau ...
Launching Bneuron - A Breakthrough Dairy Supplement For Brain Protection
SEOUL, South Korea, March 8, 2024 /PRNewswire/ -- Bneuron milk, a breakthrough product in the health and wellness industry, has been enteringSouth Korea diary market. The product is scientifically proven to offer multiple benefits for the brain and nervous system. By delivering essential nutrient...
VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in China
SHANGHAI, March 7, 2024 /PRNewswire/ -- VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, today announced that the Biologics License Application (BLA) for Lonapegsomatropin (TransCon hGH) was accepted by the China National Medical Products Admi...
Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China
WUXI, China, March 7, 2024 /PRNewswire/ -- Silk Road Medical (NASDAQ: SILK), a medical device company based inCalifornia USA and Genesis MedTech Group have signed an exclusive distribution agreement to introduce the TCAR® core products, ENROUTE® Transcarotid Neuroprotection System and ENROUTE® T...
Uniting for Women's Wellness on IWD - From China to Uzbekistan
- Interviewing Wang Leilei, the first blind model in China, and Viktoriya Tsay, head of Prenatal and Neonatal Medicine Department at Genscreen, BGI Genomics JV laboratory inUzbekistan. HONG KONG, March 8, 2024 /PRNewswire/ -- To mark International Women's Day (IWD), BGI Genomics interviewed Wang...
Pudu Robotics to Showcase Comprehensive Solutions at Australian Healthcare Week
SYDNEY, March 8, 2024 /PRNewswire/ -- Pudu Robotics ("PUDU"), the global leader in commercial service robots, is excited to announce its participation in the forthcoming Australian Healthcare Week (AHW), the biggest and most influential healthcare gathering in the southern hemisphere, scheduled f...
Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry
WUHAN, China, March 7, 2024 /PRNewswire/ -- Chime Biologics, a leading global CDMO that enables its partners' success in biologics, today announced that it has obtained ISO/IEC 27001:2022 certification on information security management systems. After passing rigorous reviews on all the items of...
P2G Foundation is Leading the Charge in Empowering Singapore's Homeless Population
SINGAPORE, March 7, 2024 /PRNewswire/ -- P2G Foundation announces its commitment to empowering lives and fostering hope forSingapore's unhoused population. With an unshakable commitment to extending support and creating pathways to opportunity, P2G Foundation emerges as a guiding light of compas...
Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions
HANGZHOU, China, March 7, 2024 /PRNewswire/ -- Zylox-Tonbridge (2190.HK, "the Company"), a leading medical device company in the peripheral and neurovascular interventional market inChina, today announced a new strategic partnership with Avinger, a commercial-stage medical device company developi...
Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024
ROCKVILLIE, Md. and SUZHOU, China, March 7, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and...
Luye Pharma's Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao
Reshaping the landscape for the second-line treatments of Small Cell Lung Cancer HONG KONG and MACAO, March 7, 2024 /PRNewswire/ -- A symposium called the New Treatment Paradigm for Small Cell Lung Cancer (SCLC) organized by the Hong Kong Cancer Therapy Society (HKCTS) with support from Luye Phar...
A Global Milestone in Innovative Pancreatic Cancer Therapy
Suppression of pancreatic cancer and increased survival rates in animals implanted with human pancreatic cancer cells when treated with biologic agent BGX, a proprietary targeted therapy developed in-house by BioGate. TAIPEI, March 7, 2024 /PRNewswire/ -- BioGate Precision Medicine Corp., a memb...
Epitomee® announces the filing of a novel Weight Loss Capsule for FDA clearance
CAESAREA, Israel, March 7, 2024 /PRNewswire/ -- Epitomee® (TASE: EPIT) announced today that onFebruary 27, 2024, it has submitted its Weight Loss Capsule for FDA clearance in theUSA, reaching a significant milestone in the company's journey. The Epitomee® capsule offers an innovative, orally adm...
Puritan's Pride Steadily Expands Its Global Influence, Securing a Leading Position Among Nutritional Brands
NEW YORK, March 6, 2024 /PRNewswire/ -- As global health awareness has increased, there has been a notable shift in people's focus from "treatment" to "prevention" of diseases. OnDecember 4, 2023, the International Self-Care Foundation and the Dietary Guidance Committee of the Chinese Aging Well ...
OnCusp Therapeutics Announces First Patient Dosed in Phase 1 Trial of CUSP06 in Patients with Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
--CUSP06 is a CDH6-directed Antibody-Drug Conjugate (ADC) with a differentiated profile and potentially best-in-class activity-- NEW YORK, March 6, 2024 /PRNewswire/ -- OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innova...
APAX Medical Introduces Cutting-Edge ADVATx Laser For Skin Rejuvenation
SINGAPORE, March 6, 2024 /PRNewswire/ -- APAX Medical & Aesthetics Clinic is proud to announce the introduction of the ADVATx laser treatment by Advalight in their offerings - a revolutionary laser system that targets both active acne and acne scars simultaneously. This innovative solution utilis...
Latest Updates of Viva Biotech's Portfolio Companies
HONG KONG, March 6, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the suc...
American, Finnish and Canadian governments fund oxygen plant at Tatu City SEZ, Kenya
Project will combat infant mortality rates and lessen fetal distress in East Africa TATU CITY, Kenya, March 6, 2024 /PRNewswire/ -- The governments of the United States, Finland and Canada are funding a sustainable, accessible and affordable medicinal oxygen manufacturing facility at Tatu City S...
Akeso Announced the First Patient Dosed in Phase III Trial of Cadonilimab(PD-1/CTLA-4) Combined with Chemotherapy versus Tislelizumab Combined with Chemotherapy in First-line Treatment of PD-L1 negative NSCLC
HONG KONG, March 6, 2024 /PRNewswire/ -- Akeso Inc. ("Akeso", 9926. HK) announced the enrollment of the first patient in the registrational Phase III clinical study comparingCadonilimab (PD-1/CTLA-4 bispecific antibody) combined with chemotherapy versus Tislelizumab (PD-1 antibody) combined with ...
Week's Top Stories
Most Reposted
Rising Through the Ranks: Giti Recorded as the Fastest-Growing Tire Brand in the World, and They Are Not Stopping There
[Picked up by 311 media titles]
2024-06-12 15:34ENERTEC ASIA 2024 IGNITES SOUTHEAST ASIA'S BATTERY AND EV TECH REVOLUTION
[Picked up by 254 media titles]
2024-06-07 09:07"Generation Z" Youth Dialogue Themed "Bridging Pipelines, Hearts Aligned: Young Vibes along the Energy Silk Road" Successfully Held in Beijing
[Picked up by 249 media titles]
2024-06-07 21:44Broad-Based ETFs Unleashing Opportunities to Invest in China A-Shares Amid Market Recovery
[Picked up by 238 media titles]
2024-06-11 10:06The Third Hong Kong Science Fair Gathers Creative Technologies of the Next Generation
[Picked up by 231 media titles]
2024-06-10 12:11